Home Metabolism Transferase inhibitor Miglustat For research use only.

Miglustat

Synonyms: Zavesca, N‐butyldeoxynojirimycin, OGT 918

Miglustat (Zavesca, N‐butyldeoxynojirimycin, OGT 918) is an orally administered ceramide glucosyltransferase inhibitor which prevents the lysosomal accumulation of glucocerebroside.

Miglustat Chemical Structure

Miglustat Chemical Structure

CAS No. 72599-27-0

Purity & Quality Control

Miglustat Related Products

Signaling Pathway

Transferase Signaling Pathways

Transferase Signaling Pathway

Biological Activity

Description

Miglustat (Zavesca, N‐butyldeoxynojirimycin, OGT 918) is an orally administered ceramide glucosyltransferase inhibitor which prevents the lysosomal accumulation of glucocerebroside.
Targets
ceramide glucosyltransferase [1]
In vitro
In vitro

Both HCT116 and Lovo cells show decreased tumor microsphere growth with pronounced growth retardation of Lovo cell spheroids at low concentrations of Miglustat. A marked elevation of SM and PC in is observed in Lovo cells treated with Miglustat.[2]
Cell Research Cell lines HCT116, Lovo cells
Concentrations 100 µM
Incubation Time 4 days
Method

Lovo and HCT116 cells are cultivated in MEM-alpha medium, cells are cultivated in 10 mL culture medium in- or without the presence of 100 µM Miglustat. Cells are cultivated in 10 cm tissue culture dishes for 4 days. Cells are counted, split and treated for another 2 days, each in triplicates. Cells are harvested and used for FACS-, protein-, and TLC-analysis.
In Vivo
In vivo

Miglustat treatment of Mcoln1−/− mice successfully delays impairments in cerebellar-mediated motor coordination, Purkinje cell death, and cerebellar microgliosis.[3]
Animal Research Animal Models Mcoln1−/− mice
Dosages 300 mg/kg
Administration i.p.
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05174039 Active not recruiting
Batten Disease
Beyond Batten Disease Foundation|Theranexus
 February 2 2022 Phase 1|Phase 2
NCT02185651 Terminated
Pompe Disease|Hypersensitivity Reaction
University of Florida|Amicus Therapeutics
 October 2016 Phase 1
NCT00194649 Completed
Contraception
University of Washington|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
 June 2005 Phase 4
NCT00418847 Completed
Gangliosidoses GM2
The Hospital for Sick Children|Actelion
 July 2004 Phase 2

Chemical Information & Solubility

Molecular Weight 219.28 Formula

C10H21NO4
CAS No. 72599-27-0 SDF --
Storage (From the date of receipt) 3 years -20°C powder

In vitro
Batch:

DMSO : 44 mg/mL ( (200.65 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : 44 mg/mL

Ethanol : 22 mg/mL


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Miglustat | Miglustat supplier | purchase Miglustat | Miglustat cost | Miglustat manufacturer | order Miglustat | Miglustat distributor